Skip to main content
OZEM logo

Roundhill GLP-1 & Weight Loss ETF

OZEMNASDAQRoundhillEquity

$30.75Today:−$0.67 (−2.12%)1Y −4.53%

As of Nov 16, 2026 close

Assets (AUM)
$56.64M
Expense ratio
0.59%
Dividend yield
1.33%
Holdings
25
52-week range
$28.34$37.15
Volume (live)
-
Avg. volume (3M)
10.52K

OZEM ETF: Roundhill GLP-1 & Weight Loss ETF - Price, Holdings & Analysis

Roundhill GLP-1 & Weight Loss ETF Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fund characteristics, expense ratio, dividend yield, and performance metrics

Price & Trading Activity
Day's Range$30.75 - $31.46
52-Week High$37.15
52-Week Low$28.34
Open$31.21
Volume (last close)7.53K
Average Volume (3M)10.52K
Performance Metrics
1 Day Change−2.12%
1 Month Change+5.13%
6 Month Change−0.33%
YTD Change−10.46%
1 Year Change−4.53%
Dividend Information
Annual Dividend$0.41
Dividend Yield1.33%
Last Dividend Ex-DateDec 30, 2025
Dividend Growth YoY+673.58%
Years Dividend Growth1
Fund Characteristics
Assets (AUM)$56.64M
Expense Ratio0.59%
Total Holdings25
Inception DateMay 20, 2024
Technical Indicators
50-Day MA$30.58
200-Day MA$31.86
RSI50.21
Stochastic %K53.61
Stochastic %D70.44

Source: Exchange price data and fund disclosures. Data as of Nov 16, 2026. Data sources and methodology

Compare OZEM with other ETFs

OZEM at a Glance

Roundhill GLP-1 & Weight Loss ETF (OZEM) is an equity ETF from Roundhill, launched in May 2024. It manages $56.64M in assets and charges a 0.59% expense ratio, about $59 a year per $10,000 invested.

Based on holdings data updated Oct 4, 2026, it holds 25 positions. The largest are Eli Lilly and Company (LLY, 12.90%), Novo Nordisk A/S (NVO, 12.05%) and Pfizer Inc. (PFE, 7.72%). The top 10 holdings make up 67.6% of the fund. By sector it leans toward Healthcare (100.0%). Its largest country exposures are United States (41.8%), Denmark (27.8%) and China (12.4%).

It pays distributions yielding 1.33% at the Nov 16, 2026 close, $0.41 per share over the trailing 12 months. As of the Nov 16, 2026 close, the share price is down 4.5% over one year (price change, excluding distributions).

Frequently Asked Questions About Roundhill GLP-1 & Weight Loss ETF

What is the current price of OZEM?

The latest OZEM price is $30.75 (Nov 16, 2026 close). The 52-week range is $28.34–$37.15. The share price is down 4.5% over the past year (price change, excluding distributions).

What is the expense ratio for OZEM?

OZEM's annual expense ratio is 0.59%, about $59 a year for every $10,000 invested.

Does OZEM pay dividends?

Yes, OZEM pays a 1.33% dividend yield (trailing 12 months, at the Nov 16, 2026 close). The most recent ex-dividend date was December 30, 2025. View full dividend history in the Dividends section.

What are the top holdings of OZEM?

In holdings data last updated Oct 4, 2026, OZEM's largest holdings are Eli Lilly and Company (12.9%), Novo Nordisk A/S (12.0%), Pfizer Inc. (7.7%) (combined weight: 32.7%). The fund holds 25 total positions. View the complete portfolio breakdown in the Holdings section.

How concentrated is OZEM's portfolio?

In holdings data updated Oct 4, 2026, the top 10 holdings make up 67.6% of OZEM's assets across 25 positions. Its largest sector weight is Healthcare at 100.0%.

How large is OZEM and when did it launch?

OZEM manages $56.64M in assets. Roundhill launched the fund on May 20, 2024, about 2 years before the Nov 16, 2026 close.